Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.

ABSTRACT:

Background

The severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) has resulted in a global pandemic. Hydroxychloroquine±azithromycin have been widely used to treat coronavirus disease 2019 (COVID-19) despite a paucity of evidence regarding efficacy. The incidence of torsade de pointes remains unknown. Widespread use of these medications forced overwhelmed health care systems to search for ways to effectively monitor these patients while simultaneously trying to minimize health care provider exposure and use of personal protective equipment.

Methods

Patients with COVID-19 positive who received hydroxychloroquine±azithromycin across 13 hospitals between March 1 and April 15 were included in this study. A comprehensive search of the electronic medical records was perf

SUBMITTER: Saleh M 

PROVIDER: S-EPMC7668332 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature